A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer
Clinical trial NCT00811135 · COMPLETED
Trial details
- NCT number
- NCT00811135
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2015-12-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.